Gene expression profiling of prostatectomy specimens also showed that higher PD-L2 expression was prognostic, associated with worse biochemical recurrence, metastatic spread, and prostate cancer specific survival [16]. The gene discussed is PDCD1LG2; the disease is Familial prostate cancer.